Criteria Bio Ventures

Earlier today, our team members Ruben Sebastian-Perez and Salvatore Cappadona participated in the Early-Stage Therapeutics and Oncology Innovation panels at #RESIEurope2024. We shared success stories and experiences from our portfolio and discussed exciting trends we are closely monitoring with great interest in oncology, metabolic diseases, autoimmunity, cardio, and beyond! Reach out to our team attending if you would like to exchange thoughts on innovative therapeutic opportunities. Salvatore Cappadona | Ruben Sebastian-Perez | Sebastián Chiavenna #RESIEurope #biotech #innovation #venturecapital

Ha sido un placer participar en el #InformeAseBio2023 "25 años de biotecnología", presentado ayer, y que detalla los principales indicadores del sector biotecnológico en España y su evolución en el último cuarto de siglo. Felicitamos a AseBio - Asociación Española de Bioempresas por sus 25 años de trabajo dedicado a fortalecer el sector biotecnológico en España y a todos aquellos que han contribuido a fortalecer un sector que impacta significativamente en la calidad de vida de las personas y en el crecimiento económico y social. Enhorabuena Ion Arocena y a todo el equipo de ASEBIO por el esfuerzo y dedicación para que la biotecnología en España sea un actor de relevancia. #ASEBIO #Biotech #Pharma

🌟 Exciting news on our portfolio company Minoryx Therapeutics! 🌟 We are pleased to share groundbreaking findings recently published in Brain by #Minoryx team and Dr. Fanny Mochel, who led the clinical study. The study reveals that #leriglitazone has demonstrated remarkable efficacy in halting disease progression in adult patients with progressive #cALD, a devastating neurodegenerative disorder characterized by demyelinating brain lesions. This breakthrough marks a significant advancement in our understanding and treatment of #cALD, offering hope to those affected and their families. It underscores the power of innovative research and collaboration in pushing the boundaries of medicine. Kudos to the dedicated researchers and healthcare professionals involved in this critical work. Your commitment to improving patient outcomes is truly inspiring. Let's continue to support and accelerate research efforts towards finding effective treatments for neurodegenerative diseases. https://lnkd.in/dJbbR3H9 #Neurology #BrainHealth #HealthcareInnovation #Biotech #VC

I will be speaking on the Oncology Innovation panel at RESI Europe 2024 next Monday, June 17. I appreciate the kind invitation from the organizing committee. During this panel, we will explore the next big breakthroughs in the oncology space and the technologies and mechanisms we, as investors, find most compelling to drive patient benefit. I’m eager to share my insights and exchange reflections with fellow panelists. If you are attending, don’t miss out! Criteria Bio Ventures | Life Science Nation | Biocat, BioRegion of Catalonia #RESI #RESIEurope #oncology #biotech #venturecapital

We are attending AseBio Investor Day! A fantastic event to feel the pulse of the Spanish biotech ecosystem. Pablo Cironi | Ruben Sebastian-Perez #AseBioID2024 #partnering #biotech #venturecapital AseBio - Asociación Española de Bioempresas

Next week the Criteria Bio Ventures team will be on-site attending the 24th BioEquity Europe in San Sebastian to meet biotech entrepreneurs and catch up with industry leaders and fellow VC investors. We look forward to connecting with #biopharma colleagues who are making a change in the life sciences sector. If you are also participating, get in touch with Pablo Cironi and Ruben Sebastian-Perez to arrange a meet up! 🤝 BioCentury Inc. | EBD Group #BioEquityEurope #partnering #biotech #pharma #innovation #venturecapital #lifesciences

Next week the Criteria Bio Ventures team will be on-site attending BIO-Europe Spring 2024 in our hometown Barcelona to meet biotech entrepreneurs and catch up with industry leaders and fellow VC investors. We look forward to connecting with #biopharma colleagues who are making a change in the life sciences sector. If you are also participating, get in touch with Sebastián Chiavenna, Salvatore Cappadona and Ruben Sebastian-Perez to arrange a meet up! 🤝 EBD Group | Criteria Bio Ventures | Caixa Capital Risc #BIOEuropeSpring #partnering #biotech #pharma #innovation #venturecapital #lifesciences

We are happy to announce the well-deserved promotions of Ruben Sebastian-Perez and Salvatore Cappadona to Senior Associates within our investment team 🚀 This is a recognition of their exceptional talent, dedication, and invaluable contributions, which have been instrumental in driving our mission forward and shaping the future of Criteria Bio Ventures. Please join us in congratulating Ruben and Salvatore on their new roles! We look forward to their continued leadership and contributions to the success of our organization. https://lnkd.in/d3Tuegbu #CBVteam #promotions #venturecapital #careermilestones

Today Pablo Cironi, Managing Director, and Ruben Sebastian-Perez, Senior Associate, are representing Criteria Bio Ventures at CNIO Investor's Day 2024. Such a great event to interact with the scientific and innovation community of one of the leading cancer research centers worldwide. CNIO - Spanish National Cancer Research Centre #cancerresearch #cancertherapy #innovation